Laboratory Corp Analyst Ratings
Laboratory Corp Analyst Ratings
實驗室公司分析師評級
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/03/2023 | 21.38% | Morgan Stanley | $285 → $260 | Maintains | Overweight |
| 08/02/2023 | 7.84% | Credit Suisse | $247.41 → $231 | Maintains | Outperform |
| 07/31/2023 | 17.18% | Baird | $255 → $251 | Maintains | Outperform |
| 07/28/2023 | 26.05% | Truist Securities | $275 → $270 | Maintains | Buy |
| 06/05/2023 | 34.45% | Credit Suisse | → $288 | Reiterates | Outperform → Outperform |
| 05/16/2023 | 19.98% | Mizuho | $277 → $257 | Maintains | Buy |
| 05/10/2023 | 33.05% | Morgan Stanley | $295 → $285 | Maintains | Overweight |
| 05/01/2023 | 28.38% | Truist Securities | $285 → $275 | Maintains | Buy |
| 03/13/2023 | 34.45% | Credit Suisse | $304 → $288 | Maintains | Outperform |
| 02/21/2023 | 41.92% | Credit Suisse | $305 → $304 | Maintains | Outperform |
| 02/21/2023 | 35.39% | Wells Fargo | $315 → $290 | Maintains | Overweight |
| 02/17/2023 | 33.05% | Truist Securities | $275 → $285 | Maintains | Buy |
| 02/17/2023 | 21.38% | Citigroup | $250 → $260 | Maintains | Neutral |
| 02/17/2023 | 40.06% | Baird | $285 → $300 | Maintains | Outperform |
| 02/17/2023 | 29.32% | Mizuho | $250 → $277 | Maintains | Buy |
| 01/11/2023 | 33.05% | Baird | $270 → $285 | Maintains | Outperform |
| 01/06/2023 | 41.46% | Morgan Stanley | $290 → $303 | Maintains | Overweight |
| 12/12/2022 | 16.71% | Citigroup | → $250 | Downgrades | Buy → Neutral |
| 11/23/2022 | 42.39% | Credit Suisse | $308 → $305 | Maintains | Outperform |
| 11/03/2022 | 16.71% | Mizuho | $296 → $250 | Maintains | Buy |
| 10/31/2022 | 35.39% | Morgan Stanley | $300 → $290 | Maintains | Overweight |
| 10/28/2022 | 21.38% | Truist Securities | $275 → $260 | Maintains | Buy |
| 08/22/2022 | 40.06% | Morgan Stanley | → $300 | Assumes | → Overweight |
| 08/01/2022 | 43.79% | Credit Suisse | $312 → $308 | Maintains | Outperform |
| 07/29/2022 | 38.19% | Mizuho | $323 → $296 | Maintains | Buy |
| 05/25/2022 | 40.06% | Morgan Stanley | $360 → $300 | Maintains | Overweight |
| 05/03/2022 | 23.72% | Deutsche Bank | $294 → $265 | Maintains | Hold |
| 05/02/2022 | 45.66% | Credit Suisse | $344 → $312 | Maintains | Outperform |
| 04/25/2022 | 47.06% | Wells Fargo | $320 → $315 | Maintains | Overweight |
| 02/14/2022 | 68.07% | Morgan Stanley | $380 → $360 | Maintains | Overweight |
| 02/11/2022 | 60.6% | Credit Suisse | $340 → $344 | Maintains | Outperform |
| 01/28/2022 | 37.25% | Deutsche Bank | → $294 | Downgrades | Buy → Hold |
| 12/20/2021 | 65.27% | Mizuho | $332 → $354 | Maintains | Buy |
| 12/17/2021 | 77.4% | Morgan Stanley | $377 → $380 | Maintains | Overweight |
| 12/14/2021 | 58.73% | Wells Fargo | $330 → $340 | Maintains | Overweight |
| 11/01/2021 | 57.8% | Credit Suisse | $336 → $338 | Maintains | Outperform |
| 10/29/2021 | 76% | Morgan Stanley | $368 → $377 | Maintains | Overweight |
| 08/31/2021 | 71.8% | Morgan Stanley | $273 → $368 | Maintains | Overweight |
| 08/20/2021 | 56.86% | Credit Suisse | $296 → $336 | Maintains | Outperform |
| 08/19/2021 | 55% | Mizuho | $318 → $332 | Maintains | Buy |
| 07/30/2021 | 54.06% | Deutsche Bank | $297 → $330 | Maintains | Buy |
| 07/30/2021 | 48.46% | Mizuho | $310 → $318 | Maintains | Buy |
| 05/20/2021 | 37.72% | Argus Research | $270 → $295 | Maintains | Buy |
| 05/12/2021 | 44.72% | Mizuho | $267 → $310 | Maintains | Buy |
| 05/03/2021 | 44.72% | Jefferies | $300 → $310 | Maintains | Buy |
| 04/14/2021 | 40.06% | Truist Securities | $280 → $300 | Maintains | Buy |
| 02/12/2021 | 24.65% | Mizuho | $242 → $267 | Maintains | Buy |
| 02/12/2021 | 29.79% | Citigroup | $257 → $278 | Maintains | Buy |
| 01/29/2021 | 19.98% | Citigroup | $249 → $257 | Maintains | Buy |
| 01/14/2021 | 12.98% | Mizuho | $234 → $242 | Maintains | Buy |
| 01/11/2021 | — | Argus Research | Upgrades | Hold → Buy | |
| 10/28/2020 | 21.38% | Wells Fargo | $225 → $260 | Maintains | Overweight |
| 07/29/2020 | 12.04% | B of A Securities | $220 → $240 | Maintains | Buy |
| 07/14/2020 | 2.71% | B of A Securities | $194 → $220 | Upgrades | Neutral → Buy |
| 07/13/2020 | 1.31% | Wolfe Research | $202 → $217 | Upgrades | Peer Perform → Outperform |
| 06/08/2020 | 2.24% | Baird | $199 → $219 | Maintains | Outperform |
| 06/02/2020 | -1.96% | Deutsche Bank | → $210 | Reinstates | → Buy |
| 05/21/2020 | 2.71% | SunTrust Robinson Humphrey | $200 → $220 | Maintains | Buy |
| 05/20/2020 | 13.91% | Morgan Stanley | $241 → $244 | Maintains | Overweight |
| 05/15/2020 | -13.17% | Mizuho | $158 → $186 | Upgrades | Neutral → Buy |
| 05/05/2020 | 1.77% | UBS | $209 → $218 | Maintains | Buy |
| 04/30/2020 | 12.51% | Morgan Stanley | $172 → $241 | Maintains | Overweight |
| 04/30/2020 | -11.3% | B of A Securities | $147 → $190 | Reiterates | → Neutral |
| 04/27/2020 | -0.09% | Citigroup | $204 → $214 | Upgrades | Neutral → Buy |
| 04/23/2020 | -8.96% | Barclays | $188 → $195 | Maintains | Overweight |
| 04/16/2020 | -26.24% | Mizuho | $163 → $158 | Maintains | Neutral |
| 04/13/2020 | -6.63% | SunTrust Robinson Humphrey | $225 → $200 | Maintains | Buy |
| 04/08/2020 | -19.7% | Morgan Stanley | $211 → $172 | Maintains | Overweight |
| 04/02/2020 | -30.44% | JP Morgan | $149 → $149 | Maintains | Overweight |
| 03/30/2020 | -20.63% | Wells Fargo | $215 → $170 | Maintains | Overweight |
| 03/30/2020 | -20.63% | Keybanc | $212 → $170 | Maintains | Overweight |
| 03/26/2020 | -12.23% | Barclays | $212 → $188 | Maintains | Overweight |
| 02/25/2020 | -11.3% | Mizuho | $174 → $190 | Maintains | Neutral |
| 02/18/2020 | -1.49% | Morgan Stanley | $199 → $211 | Maintains | Overweight |
| 02/14/2020 | -4.76% | Citigroup | $179 → $204 | Maintains | Neutral |
| 01/08/2020 | -1.96% | Wells Fargo | → $210 | Initiates Coverage On | → Overweight |
| 10/21/2019 | -6.63% | UBS | $204 → $200 | Maintains | Buy |
| 08/23/2019 | -6.16% | Morgan Stanley | $190 → $201 | Maintains | Overweight |
| 08/08/2019 | -10.36% | Keybanc | $172 → $192 | Maintains | Overweight |
| 07/26/2019 | -11.3% | Morgan Stanley | $175 → $190 | Maintains | Overweight |
| 07/16/2019 | — | B of A Securities | Upgrades | Underperform → Neutral | |
| 06/21/2019 | 2.71% | Deutsche Bank | $180 → $220 | Upgrades | Hold → Buy |
| 05/02/2019 | -22.97% | Canaccord Genuity | $155 → $165 | Maintains | Hold |
| 05/01/2019 | -17.83% | Citigroup | $157 → $176 | Maintains | Neutral |
| 05/01/2019 | -8.96% | UBS | $178 → $195 | Maintains | Buy |
| 04/02/2019 | — | Jefferies | Upgrades | Hold → Buy | |
| 03/18/2019 | -19.23% | Barclays | $165 → $173 | Maintains | Overweight |
| 02/27/2019 | -23.44% | Credit Suisse | $160 → $164 | Maintains | Outperform |
| 01/17/2019 | -21.1% | UBS | → $169 | Initiates Coverage On | → Buy |
| 01/03/2019 | — | B of A Securities | Downgrades | Neutral → Underperform | |
| 12/06/2018 | -22.97% | Keybanc | $210 → $165 | Maintains | Overweight |
| 12/03/2018 | -22.97% | Barclays | $205 → $165 | Maintains | Overweight |
| 12/03/2018 | -25.3% | Citigroup | $171 → $160 | Maintains | Neutral |
| 12/03/2018 | -27.64% | Canaccord Genuity | $162 → $155 | Maintains | Hold |
| 12/03/2018 | -15.97% | Morgan Stanley | $202 → $180 | Maintains | Overweight |
| 11/30/2018 | -15.97% | Goldman Sachs | $190 → $180 | Downgrades | Conviction Buy → Buy |
| 10/30/2018 | — | Argus Research | Downgrades | Buy → Hold | |
| 10/25/2018 | -11.3% | Baird | $205 → $190 | Maintains | Outperform |
| 10/25/2018 | -20.17% | Citigroup | $184 → $171 | Maintains | Neutral |
| 10/25/2018 | -24.37% | Canaccord Genuity | $195 → $162 | Downgrades | Buy → Hold |
| 09/10/2018 | -5.7% | Morgan Stanley | $192 → $202 | Maintains | Overweight |
| 09/04/2018 | -8.96% | Credit Suisse | $197 → $195 | Maintains | Outperform |
| 08/20/2018 | -11.3% | Deutsche Bank | $195 → $190 | Maintains | Hold |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 08/03/2023 | 21.38% | 摩根士丹利 | $285→$260 | 維護 | 超重 |
| 08/02/2023 | 7.84% | 瑞士信貸 | $247.41→$231 | 維護 | 跑贏大盤 |
| 07/31/2023 | 17.18% | 貝爾德 | $255→$251 | 維護 | 跑贏大盤 |
| 07/28/2023 | 26.05% | Truist證券 | $275→$270 | 維護 | 買 |
| 06/05/2023 | 34.45% | 瑞士信貸 | →$288 | 重申 | 跑贏→跑贏大盤 |
| 2023年05月16日 | 19.98% | 瑞穗 | $277→$257 | 維護 | 買 |
| 2023年05月10日 | 33.05% | 摩根士丹利 | $295→$285 | 維護 | 超重 |
| 05/01/2023 | 28.38% | Truist證券 | $285→$275 | 維護 | 買 |
| 03/13/2023 | 34.45% | 瑞士信貸 | $304→$288 | 維護 | 跑贏大盤 |
| 02/21/2023 | 41.92% | 瑞士信貸 | $305→$304 | 維護 | 跑贏大盤 |
| 02/21/2023 | 35.39% | 富國銀行 | $315→$290 | 維護 | 超重 |
| 02/17/2023 | 33.05% | Truist證券 | $275→$285 | 維護 | 買 |
| 02/17/2023 | 21.38% | 花旗集團 | $250→$260 | 維護 | 中性 |
| 02/17/2023 | 40.06% | 貝爾德 | $285→$300 | 維護 | 跑贏大盤 |
| 02/17/2023 | 29.32% | 瑞穗 | $250→$277 | 維護 | 買 |
| 2023年1月11日 | 33.05% | 貝爾德 | $270→$285 | 維護 | 跑贏大盤 |
| 01/06/2023 | 41.46% | 摩根士丹利 | $290→$303 | 維護 | 超重 |
| 2022年12月12日 | 16.71% | 花旗集團 | →$250 | 評級下調 | 購買→中性 |
| 2022年11月23日 | 42.39% | 瑞士信貸 | $308→$305 | 維護 | 跑贏大盤 |
| 11/03/2022 | 16.71% | 瑞穗 | $296→$250 | 維護 | 買 |
| 2022年10月31日 | 35.39% | 摩根士丹利 | $300→$290 | 維護 | 超重 |
| 10/28/2022 | 21.38% | Truist證券 | $275→$260 | 維護 | 買 |
| 2022/08/22 | 40.06% | 摩根士丹利 | →$300 | 假設 | →超重 |
| 08/01/2022 | 43.79% | 瑞士信貸 | $312→$308 | 維護 | 跑贏大盤 |
| 07/29/2022 | 38.19% | 瑞穗 | $323→$296 | 維護 | 買 |
| 2022年05月25日 | 40.06% | 摩根士丹利 | $360→$300 | 維護 | 超重 |
| 05/03/2022 | 23.72% | 德意志銀行 | $294→$265 | 維護 | 保持 |
| 05/02/2022 | 45.66% | 瑞士信貸 | $344→$312 | 維護 | 跑贏大盤 |
| 04/25/2022 | 47.06% | 富國銀行 | $320→$315 | 維護 | 超重 |
| 02/14/2022 | 68.07% | 摩根士丹利 | $380→$360 | 維護 | 超重 |
| 02/11/2022 | 60.6% | 瑞士信貸 | $340→$344 | 維護 | 跑贏大盤 |
| 2022年01月28日 | 37.25% | 德意志銀行 | →$294 | 評級下調 | 購買→Hold |
| 12/20/2021 | 65.27% | 瑞穗 | $332→$354 | 維護 | 買 |
| 2021/12/17 | 77.4% | 摩根士丹利 | $377→$380 | 維護 | 超重 |
| 2021年12月14日 | 58.73% | 富國銀行 | $330→$340 | 維護 | 超重 |
| 11/01/2021 | 57.8% | 瑞士信貸 | $336→$338 | 維護 | 跑贏大盤 |
| 10/29/2021 | 百分之七十六 | 摩根士丹利 | $368→$377 | 維護 | 超重 |
| 2021/08/31 | 71.8% | 摩根士丹利 | $273→$368 | 維護 | 超重 |
| 08/20/2021 | 56.86% | 瑞士信貸 | $296→$336 | 維護 | 跑贏大盤 |
| 2021/08/19 | 55% | 瑞穗 | $318→$332 | 維護 | 買 |
| 07/30/2021 | 54.06% | 德意志銀行 | $297→$330 | 維護 | 買 |
| 07/30/2021 | 48.46% | 瑞穗 | $310→$318 | 維護 | 買 |
| 05/20/2021 | 37.72% | Argus研究 | $270→$295 | 維護 | 買 |
| 2021/05/12 | 44.72% | 瑞穗 | $267→$310 | 維護 | 買 |
| 05/03/2021 | 44.72% | 傑富瑞 | $300→$310 | 維護 | 買 |
| 04/14/2021 | 40.06% | Truist證券 | $280→$300 | 維護 | 買 |
| 02/12/2021 | 24.65% | 瑞穗 | $242→$267 | 維護 | 買 |
| 02/12/2021 | 29.79% | 花旗集團 | $257→$278 | 維護 | 買 |
| 2021/01/29 | 19.98% | 花旗集團 | $249→$257 | 維護 | 買 |
| 2021/01/14 | 12.98% | 瑞穗 | $234→$242 | 維護 | 買 |
| 2021/11/01 | - | Argus研究 | 升級 | 持有→購買 | |
| 10/28/2020 | 21.38% | 富國銀行 | $225→$260 | 維護 | 超重 |
| 07/29/2020 | 12.04% | B of A證券 | $220→$240 | 維護 | 買 |
| 07/14/2020 | 2.71% | B of A證券 | $194→$220 | 升級 | 中性→購買 |
| 07/13/2020 | 1.31% | 沃爾夫研究 | $202→$217 | 升級 | 同業表現優於→ |
| 06/08/2020 | 2.24% | 貝爾德 | $199→$219 | 維護 | 跑贏大盤 |
| 06/02/2020 | -1.96% | 德意志銀行 | →$210 | 恢復 | →購買 |
| 2020/05/21 | 2.71% | SunTrust Robinson Humphrey | $200→$220 | 維護 | 買 |
| 05/20/2020 | 13.91% | 摩根士丹利 | $241→$244 | 維護 | 超重 |
| 2020/05/15 | -13.17% | 瑞穗 | $158→$186 | 升級 | 中性→購買 |
| 05/05/2020 | 1.77% | 瑞銀集團 | $209→$218 | 維護 | 買 |
| 04/30/2020 | 12.51% | 摩根士丹利 | $172→$241 | 維護 | 超重 |
| 04/30/2020 | -11.3% | B of A證券 | $147→$190 | 重申 | →中性 |
| 04/27/2020 | -0.09% | 花旗集團 | $204→$214 | 升級 | 中性→購買 |
| 04/23/2020 | -8.96% | 巴克萊 | $188→$195 | 維護 | 超重 |
| 04/16/2020 | -26.24% | 瑞穗 | $163→$158 | 維護 | 中性 |
| 04/13/2020 | -6.63% | SunTrust Robinson Humphrey | $225→$200 | 維護 | 買 |
| 04/08/2020 | -19.7% | 摩根士丹利 | $211→$172 | 維護 | 超重 |
| 04/02/2020 | -30.44% | 摩根大通 | $149→$149 | 維護 | 超重 |
| 03/30/2020 | -20.63% | 富國銀行 | $215→$170 | 維護 | 超重 |
| 03/30/2020 | -20.63% | KeyBanc | $212→$170 | 維護 | 超重 |
| 03/26/2020 | -12.23% | 巴克萊 | $212→$188 | 維護 | 超重 |
| 02/25/2020 | -11.3% | 瑞穗 | $174→$190 | 維護 | 中性 |
| 02/18/2020 | -1.49% | 摩根士丹利 | $199→$211 | 維護 | 超重 |
| 02/14/2020 | -4.76% | 花旗集團 | $179→$204 | 維護 | 中性 |
| 1/08/2020 | -1.96% | 富國銀行 | →$210 | 開始承保 | →超重 |
| 2019年10月21日 | -6.63% | 瑞銀集團 | $204→$200 | 維護 | 買 |
| 2019年08月23日 | -6.16% | 摩根士丹利 | $190→$201 | 維護 | 超重 |
| 2019年08月08日 | -10.36% | KeyBanc | $172→$192 | 維護 | 超重 |
| 2019年07月26日 | -11.3% | 摩根士丹利 | $175→$190 | 維護 | 超重 |
| 2019年07月16日 | - | B of A證券 | 升級 | 表現不佳的→中性 | |
| 2019年06月21日 | 2.71% | 德意志銀行 | $180→$220 | 升級 | 持有→購買 |
| 2019年05月02日 | -22.97% | 卡納科特·格納奇 | $155→$165 | 維護 | 保持 |
| 2019年05月01日 | -17.83% | 花旗集團 | $157→$176 | 維護 | 中性 |
| 2019年05月01日 | -8.96% | 瑞銀集團 | $178→$195 | 維護 | 買 |
| 2019年02月04日 | - | 傑富瑞 | 升級 | 持有→購買 | |
| 2019/03/18 | -19.23% | 巴克萊 | $165→$173 | 維護 | 超重 |
| 2019年02月27日 | -23.44% | 瑞士信貸 | $160→$164 | 維護 | 跑贏大盤 |
| 2019年01月17日 | -21.1% | 瑞銀集團 | →$169 | 開始承保 | →購買 |
| 2019年03月01日 | - | B of A證券 | 評級下調 | 中性→表現不佳 | |
| 2018年12月06日 | -22.97% | KeyBanc | $210→$165 | 維護 | 超重 |
| 12/03/2018 | -22.97% | 巴克萊 | $205→$165 | 維護 | 超重 |
| 12/03/2018 | -25.3% | 花旗集團 | $171→$160 | 維護 | 中性 |
| 12/03/2018 | -27.64% | 卡納科特·格納奇 | $162→$155 | 維護 | 保持 |
| 12/03/2018 | -15.97% | 摩根士丹利 | $202→$180 | 維護 | 超重 |
| 2018年11月30日 | -15.97% | 高盛 | $190→$180 | 評級下調 | 定罪購買→購買 |
| 2018年10月30日 | - | Argus研究 | 評級下調 | 購買→Hold | |
| 2018年10月25日 | -11.3% | 貝爾德 | $205→$190 | 維護 | 跑贏大盤 |
| 2018年10月25日 | -20.17% | 花旗集團 | $184→$171 | 維護 | 中性 |
| 2018年10月25日 | -24.37% | 卡納科特·格納奇 | $195→$162 | 評級下調 | 購買→Hold |
| 2018年09月10日 | -5.7% | 摩根士丹利 | $192→$202 | 維護 | 超重 |
| 2018/09/04 | -8.96% | 瑞士信貸 | $197→$195 | 維護 | 跑贏大盤 |
| 2018/08/20 | -11.3% | 德意志銀行 | $195→$190 | 維護 | 保持 |
What is the target price for Laboratory Corp (LH)?
實驗室公司(LH)的目標價格是多少？
The latest price target for Laboratory Corp (NYSE: LH) was reported by Morgan Stanley on August 3, 2023. The analyst firm set a price target for $260.00 expecting LH to rise to within 12 months (a possible 21.38% upside). 23 analyst firms have reported ratings in the last year.
實驗室公司(紐約證券交易所代碼：LH)的最新目標價是由摩根士丹利於2023年8月3日報道的。這家分析公司將目標價定為260.00美元，預計LH將在12個月內上漲至21.38%(可能上漲21.38%)。過去一年，23家分析公司公佈了評級。
What is the most recent analyst rating for Laboratory Corp (LH)?
實驗室公司(實驗室)的最新分析師評級是多少？
The latest analyst rating for Laboratory Corp (NYSE: LH) was provided by Morgan Stanley, and Laboratory Corp maintained their overweight rating.
實驗室公司(紐約證券交易所股票代碼：LH)的最新分析師評級由摩根士丹利提供，實驗室公司維持其增持評級。
When is the next analyst rating going to be posted or updated for Laboratory Corp (LH)?
實驗室公司(LH)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Laboratory Corp, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Laboratory Corp was filed on August 3, 2023 so you should expect the next rating to be made available sometime around August 3, 2024.
分析師在進行了廣泛的研究後得出股票評級，其中包括查閱公共財務報表，與實驗室公司的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。實驗室公司的上一次評級是在2023年8月3日提交的，所以你應該預計下一次評級將在2024年8月3日左右的某個時候公佈。
Is the Analyst Rating Laboratory Corp (LH) correct?
分析師評級實驗室公司(LH)是正確的嗎？
While ratings are subjective and will change, the latest Laboratory Corp (LH) rating was a maintained with a price target of $285.00 to $260.00. The current price Laboratory Corp (LH) is trading at is $214.20, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的實驗室公司(LH)評級保持不變，目標價在285.00美元至260.00美元之間。實驗室公司目前的交易價格是214.20美元，超出了分析師的預測範圍。